Illumina is seeking to meet with research institutions, companies, and entrepreneurs at all stages to explore strategic partnerships, investments, and partnering opportunities. Additionally, Illumina Accelerator is interested in meeting with startups developing breakthrough applications in genomics.
Illumina is interested in:
To apply for a 1:1 Meeting from 9:30 am to 4:00 pm please complete an application below and send to [email protected]
There are no fees for these events; Preferential selection for 1-on-1 meetings will be given to academic researchers and BioForward member companies.
In addition to partnering, don't forget to join us the morning of July 22nd for a plenary session, Illumina Accelerator panel, and networking reception on July 22, 2016 to learn more about Illumina, its business development activities, and accelerator program as well as Illumina Wisconsin, formerly Epicentre Biotechnologies. Epicentre, which started in Madison in 1987, was acquired by Illumina in 2011 and has continued to expand operations in the University Research Park.
About Illumina, Inc.
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.
About Illumina Accelerator
Illumina Accelerator is the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. It provides select startups with seed investment, business guidance, access to Illumina’s sequencing systems and reagents, and fully operational lab space in the San Francisco Bay Area during each six-month funding cycle. For more information, visit http://www.illumina.com/accelerator and follow www.linkedin.com/company/illumina-accelerator.